Portfolio Companies

PET-Technology

Regional Network of PET Centers

Operating Factories

Shareholders in Portfolio Company 
RUSNANO, RosMedTechnology, MEDILUX (Hungary)

Industry Sector 
Medicine and Pharmacology

Production Location 
Cyclotrons: Elets
PET centers: Lipetsk, Orel, Tambov, Ufa, Ekaterinburg, Moscow, Kursk
Jobs to be created: 50

Investment Started:  2011

Total Budget

2.4  bln rubles
Co-investment by RUSNANO
1.20  bln rubles

Establishment of a network of regional PET centers for diagnostic procedures

In its initial stage, portfolio company PET-Technology will open positron-emission tomography centers in Bryansk, Lipetsk, Orel, Tambov, and Ufa. To provide the PET centers with the radiopharmaceuticals, the project company will establish production of isotope 18O and organize two cyclotron sites—in Lipetsk and Ufa—for production of short-lived isotopes.

PET is used for the diagnosis of cancers, including diagnosis in early stages, and for diagnosis and treatment in cardiology and neurology. Radiopharmaceuticals are selectively absorbed by tumor tissues and tissues whose metabolic activity is high. By combining into one instrument the functions of PET and computer tomography, benefits of both ensue—a three-dimensional picture of functional changes in tissue overlays a high-resolution image of the patient’s organs. PET diagnostics identify 18 percent more tumors in early stages, significantly improving prognoses and decreasing mortality.

By producing isotope 18O—which is done using low-temperature rectification in the presence of isotope exchange reactions on nanoclusters—the project will be able to meet demand from the Russian PET centers and enter the international market for diagnostic agents.

Area of application

  • Medicine

Market

  • Diagnostic services: patients
  • Isotope 18O: domestic and foreign PET centers

Competitive advantages

  • Proprietary production of essential isotope 18O
  • Proprietary production of isotopes and radiopharmaceuticals for domestic use and export